Vivasure Medical Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vivasure Medical Ltd. - overview
Established
2009
Location
Galway, -, Ireland
Primary Industry
Medical Devices & Equipment
About
Based in Ireland, Vivasure Medical Ltd. specializes in advanced polymer implants for minimally invasive vessel closure in cardiology and vascular surgery, enhancing patient outcomes with innovative solutions. Vivasure Medical Ltd. is a medical device company focused on developing advanced closure solutions for vascular procedures.
Founded in 2009 and headquartered in Galway, Ireland, the company has engaged in 10 deals to date. Its most recent funding round was a Series D, raising EUR 30. 00 mn from Haemonetics Corporation, bringing the total amount raised to EUR 30. 00 mn.
The CEO of the company is Andrew Glass. Vivasure Medical specializes in advanced polymer implants and delivery systems for minimally invasive vessel closure in cardiology, interventional radiology, and vascular surgery. The flagship product, PerQseal, is a fully synthetic absorbable implant for managing arteriotomies up to 24F, featuring automatic loading and safety mechanisms. The product's next-generation version, PerQseal+, offers seamless deployment without sutures or metal components, catering to healthcare providers across Europe.
The company operates on a direct-to-business model, supplying innovative closure devices to hospitals and medical institutions, generating revenue primarily through product sales to healthcare providers. Vivasure Medical plans to utilize the recent funding for product development and market expansion. The company is focused on launching new versions of its products and entering new geographic regions to enhance its presence. Specific future markets have not been detailed, but the funding will support strategic initiatives aimed at increasing adoption of its innovative medical devices.
Current Investors
Ascent Biomedical Ventures, Orchestra Medical Ventures, Fountain Healthcare Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Surgical Devices, Diagnostic Equipment
Website
www.vivasuremedical.com
Verticals
HealthTech, Manufacturing
Company Stage
Series D
Total Amount Raised
Subscriber access only
Vivasure Medical Ltd. - financials
| Fiscal Year Ended | Dec 31, 2018 | Dec 31, 2019 | Jan 01, 2020 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | 40,900 | 38,798 | 31,475 | 57,725 | - | - | - |
| % Revenue Growth (YoY) | - | (5.1%) | - | - | - | - | - |
| EBITDA (USD) | (6,672,650) | (5,565,366) | 1,451,391 | 1,707,003 | - | - | - |
| Operating Income (USD) | (6,784,010) | (5,705,174) | 1,451,391 | 1,627,632 | - | - | - |
| Operating Margin | (16586.8%) | (14704.8%) | 4611.3% | 2819.6% | - | - | - |
| % EBITDA Margin | (16314.5%) | (14344.5%) | 4611.3% | 2957.1% | - | - | - |
| NET Income (USD) | (8,352,951) | (7,735,818) | (7,553,605) | (10,675,226) | - | - | - |
| % Net Margin | (20422.9%) | (19938.7%) | (23998.7%) | (18493.2%) | - | - | - |
Vivasure Medical Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Stock Purchase, Unspecified Round | Completed | Vivasure Medical Ltd. | - | ||||||||
| Series D | Completed | Vivasure Medical Ltd. | - | ||||||||
| Series D | Completed | Vivasure Medical Ltd. | - | ||||||||
| Grant | Completed | Vivasure Medical Ltd. | - | ||||||||
| Venture Debt | Completed | Vivasure Medical Ltd. | - |
Displaying 1 - 5 of 11
Vivasure Medical Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.